NOV 13, 2019 9:31 AM PST

Sherlock's DNA biosensors set to make diagnostics elementary

WRITTEN BY: Tara Fernandez

Waiting anxiously to receive results from expensive diagnostic laboratory tests could soon be a thing of the past thanks to a technological breakthrough. Engineering start-up Sherlock Biosciences, in collaboration with UK diagnostics company Mologic, recently announced they are joining forces to develop sophisticated molecular diagnostic devices simple enough for anyone to use - all from the comfort of home.

Backed by funding from the Bill & Melinda Gates Foundation, this new venture aims to blend Sherlock’s proprietary synthetic biology-based platform with Mologic’s lateral flow immunoassays. The result? Easy-to-use diagnostic devices, completely bypassing the need for complicated instrumentation and expert technicians.

Lateral flow technology is already widely used for point-of-care testing, with the most common example being pregnancy test sticks. Biological samples applied to the device get drawn up through a membrane and flow over antibodies. Interactions between the sensor and a biological marker present in the sample trigger a color change that acts as a visual cue, indicating a positive or negative result. 

The difference with Mologic’s platform is that it’s exceptionally sensitive, low-cost, has a clear visual readout and can potentially be applied to many infectious diseases, for which diagnosis is at present, a complicated affair.

The strategy of this collaboration is to amplify these diagnostic capabilities by coupling them with INSPECTR™, Sherlock’s synthetic DNA biosensor platform. INSPECTR™ (an acronym for Internal Splint-Pairing Expression Cassette Translation Reaction) is the result of research performed by Sherlock’s co-founders at Harvard University. Biosensors in INSPECTR™ can detect minute amounts of a target nucleic acid sequence in blood, saliva or urine. This drives the production of a reporter protein, which can be tailored to create a signature visual signal - a colored indicator or a fluorescent glow, for example.

Speaking on the significance of this development, co-founder, CEO and President of Sherlock, Rahul K. Dhanda said, “This program will enable us to build on the power of our INSPECTR platform to create diagnostic tools that provide accurate and affordable results in virtually any setting, while working with Mologic and the Bill & Melinda Gates Foundation to develop lateral flow technology to improve global health.”

Sources: Technology Networks, Sherlock Biosciences

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 31, 2020
Immunology
Arthritis Medication Resolves Previously Untreatable Skin Condition
DEC 31, 2020
Arthritis Medication Resolves Previously Untreatable Skin Condition
Bumpy, inflamed, ring-shaped lesions on the skin—granuloma annulare (GA) is a chronic, inflammatory skin condition ...
JAN 01, 2021
Microbiology
A New Type of Antibiotics Help the Immune System Fight Pathogens
JAN 01, 2021
A New Type of Antibiotics Help the Immune System Fight Pathogens
Reporting in Nature, scientists have identified a new group of compounds that may help us get out of the antibiotic-resi ...
JAN 10, 2021
Cell & Molecular Biology
A New Way to Defend Against Mosquito-Borne Viruses
JAN 10, 2021
A New Way to Defend Against Mosquito-Borne Viruses
Mosquitoes are killers; they are thought to be responsible for the deaths of millions of people every year because of th ...
JAN 11, 2021
Cell & Molecular Biology
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
JAN 11, 2021
Ginger May Help Slow Lupus or Antiphospholipid Syndrome Progression
Naturally occurring chemicals make more appealing medicines for many people, but there is not always evidence that they' ...
JAN 13, 2021
Cardiology
Short Bursts of Exercise Boost Markers of Good Health
JAN 13, 2021
Short Bursts of Exercise Boost Markers of Good Health
Exercise is good for our health, but it seems that certain kinds of exercise are more beneficial than others. Recent res ...
JAN 22, 2021
Clinical & Molecular DX
Breast Cancer's Nasty Nine Revealed
JAN 22, 2021
Breast Cancer's Nasty Nine Revealed
Calculating an individual’s risk of developing breast cancer isn’t easy. There’s a complex interplay b ...
Loading Comments...